Evaluation of the prognostic value of fibrinolytic elements in invasive breast carcinoma patients

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Breast cancer (BrC) is one of the most serious oncological problems in the world. The aim of the study was to evaluate concentrations of tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) and their ratios: t-PA/PAI-1 and PAI-1/t-PA in breast cancer patients and in healthy individuals and to estimate the ability of fibrinolytic parameters in predicting neoplasm disease and disease relapse. One hundred and five women were enrolled in the study, including 60 cases with primary BrC, (M0) and 45 healthy females. Follow-up was completed in all BrC patients with a 16.7% recurrence rate. An immunoassay of t-PA, PAI-1 in all cases was made as well as the immunohistochemistry of estrogen and progesterone receptors, human epidermal growth factor receptor 2, E-cadherin, and Ki-67 was performed in BrC subjects. A significantly higher PAI-1 concentration in breast cancer patients below the age of 55 than in controls was obtained. According to the ROC curve analysis, the PAI-1 concentration demonstrates the most accurate prognostic value with the cut-off point at 33.91 ng/ml, with 90% sensitivity and 36% specificity, which discriminates between controls and cancer patients. However, t-PA presents the highest area under the receiver-operating characteristic curves (AUCROC)=0.634 in predicting disease relapse with the cut-off value of 5.3 ng/ml. According to the Kaplan-Meier curves, a high concentration of t-PA (>5 ng/ml) and a lower PAI-1/t-PA ratio (<7.5) are associated with shorter survival. Evaluation of plasma t-PA and PAI-1 concentrations may deliver relevant prognostic information for breast cancer patients.

References Powered by Scopus

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

67030Citations
N/AReaders
Get full text

Diversity of breast carcinoma: Histological subtypes and clinical relevance

371Citations
N/AReaders
Get full text

Cancer-associated pathways and biomarkers of venous thrombosis

305Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Tissue Plasminogen Activator as a Possible Indicator of Breast Cancer Relapse: A Preliminary, Prospective Study

4Citations
N/AReaders
Get full text

Acquired hyperfibrinolysis as the presenting sign of metastatic breast cancer: A case report

2Citations
N/AReaders
Get full text

ALDH1A3 promotes invasion and metastasis in triple-negative breast cancer by regulating the plasminogen activation pathway

1Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ruszkowska-Ciastek, B., Kwiatkowska, K., Bielawska, S., Robakowska, M., Bielawski, K., & Rhone, P. (2020). Evaluation of the prognostic value of fibrinolytic elements in invasive breast carcinoma patients. Neoplasma, 67(5), 1146–1156. https://doi.org/10.4149/NEO_2020_191022N1076

Readers' Seniority

Tooltip

Lecturer / Post doc 1

50%

PhD / Post grad / Masters / Doc 1

50%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

50%

Social Sciences 1

25%

Psychology 1

25%

Save time finding and organizing research with Mendeley

Sign up for free